Albany, NY — (SBWIRE) — 09/13/2017 — The facial injectables market is categorized on the basis of product into hyaluronic acid, polymers and particles (PPFs), botulinum toxin, and collagen. Hyaluronic acid is the largest segment of the facial injectables market and, registering a steady CAGR of 16.30% during the forecast period, this segment is anticipated to grow to a value of US$5.9 bn by 2020. Polymers and particles, on the other hand, are projected to form the fastest expanding product segment by the end of the forecast period owing to having less side effects than other facial injectable products and higher longevity of the effect.
View Full Report: http://www.transparencymarketresearch.com/facial-injectables-market.html
The market for facial injectables is also driven by the rising geriatric population, growing preference for minimally invasive procedures, and increasing longevity of the effects of facial injectable products. While product innovation and product development offer new avenues for growth, side effects of certain products have limited the adoption of facial injectables.
Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1779
The global facial injectables market is segmented on the basis of geography into Asia Pacific, North America, Europe, and Rest of the World. Accounting for a 40.9% share in 2013, North America dominates the overall market owing to the growing demand to look younger, presence of a large pool of geriatric population, higher rate of spending on aesthetic procedures, presence of highly advanced healthcare infrastructure, strict implementation of regulatory guidelines, and a well-structured regulatory framework. Asia Pacific has been identified as having the most opportunities in the facial injectables market and this region is projected to expand at the fastest pace during the forecast period. Countries such as India, South Korea, and China have greatly contributed towards the development of the Asia Pacific facial injectables market. This growth can be attributed to factors such as the rise in disposable income, presence of a large aging population base, increase in healthcare spending, rapidly developing healthcare infrastructure, a booming entertainment industry, and rising demand for aesthetic surgical procedures.
Request to Download Brochure link: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1779
The research report highlights the key players who have contributed towards the growth of the global facial injectables market and analyzes them based on aspects such as company overview, product portfolio, business strategies, financial standing, and recent developments. The players profiled in the facial injectables market report are Merz Pharma GmbH & Co. KGaA, Bloomage BioTechnology Corporation Limited, Allergan, Inc., Galderma S.A., and Ipsen Group.
Global Facial Injectables Market Market Report is available @ US$ 5795: http://www.transparencymarketresearch.com/checkout.php?rep_id=1779
About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453
Email: [email protected]
Powered by WPeMatico